Lindsay Rocco | Elixir Health Public Relations |
Matthew Pauls | President and CEO |
Dr. Fred Cohen | Chief Medical Officer |
Brian Davis | Chief Financial Officer |
Annabel Samimy | Stifel |
Hartaj Singh | Oppenheimer |
Liisa Bayko | JMP Securities |
Elemer Piros | Cantor Fitzgerald |
Good day, ladies and gentlemen, and welcome to the Strongbridge Biopharma plc Corporate Update and Q3 2018 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to introduce your host for today's conference, Ms. Lindsay Rocco of Elixir Health Public Relations.
You may begin.